Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Neuropeptides|December 31, 2003
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptideJosef Arlt, Holger Jahn, Michael Kellner, et al.Psychoneuroendocrinology|September 17, 2019
Copeptin in CCK-4-induced panic in healthy man: Sexual dimorphisms in secretion pattern and panic response, but no correlation of copeptin with panic symptomsMichael Kellner, Peter Zwanzger, Rainer Rupprecht, et al.Psychiatry Research|April 3, 2002
Prolactin but not ACTH increases during sodium lactate-induced panic attacksChristian Otte, Michael Kellner, Josef Arlt, et al.Psychiatry Research|December 16, 2018
Impact of physical or sexual childhood abuse on plasma DHEA, DHEA-S and cortisol in a low-dose dexamethasone suppression test and on cardiovascular risk parameters in adult patients with major depression or anxiety disordersMichael Kellner, Christoph Muhtz, Åsa Weinås, et al.Psychiatry Research|August 9, 2020
Cortisol, DHEA and DHEA-S during exposure therapy in patients with obsessive-compulsive disorder - secretion patterns and prediction of treatment responseMichael Kellner, Alexander Yassouridis, Fred Adel, et al.Journal of Clinical Psychopharmacology|July 17, 2013
No effects of antidepressants on negative symptoms in schizophreniaKim Hinkelmann, Alexander Yassouridis, Michael Kellner, et al.Journal of Psychiatric Research|July 30, 2023
Copeptin response to panic provocation with CO<sub>2</sub> in healthy adultsJana Christina Müller, Charlotte Walter, Nicole Leibold, et al.Cancer Chemotherapy and Pharmacology|September 19, 2003
Acute effects of megestrol on the hypothalamic-pituitary-adrenal axisThomas J Raedler, Holger Jahn, Birgit Goedeken, et al.Journal of Psychiatric Research|November 14, 2009
Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept studyChristian Otte, Kim Hinkelmann, Steffen Moritz, et al.Journal of Psychiatric Research|October 22, 2008
The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotypeMichael Kellner, Christoph Muhtz, Cüneyt Demiralay, et al.Pageof 9